Rhumbline Advisers Buys 10,700 Shares of Tivity Health (NASDAQ:TVTY)

Rhumbline Advisers increased its stake in Tivity Health (NASDAQ:TVTY) by 15.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 81,825 shares of the company’s stock after purchasing an additional 10,700 shares during the quarter. Rhumbline Advisers owned approximately 0.21% of Tivity Health worth $2,991,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of TVTY. Nationwide Fund Advisors grew its position in Tivity Health by 20.4% in the third quarter. Nationwide Fund Advisors now owns 238,768 shares of the company’s stock valued at $9,742,000 after acquiring an additional 40,492 shares during the period. Crossmark Global Holdings Inc. bought a new stake in Tivity Health in the third quarter valued at $279,000. SG Americas Securities LLC bought a new stake in Tivity Health in the third quarter valued at $210,000. Lbmc Investment Advisors LLC grew its position in Tivity Health by 296.3% in the third quarter. Lbmc Investment Advisors LLC now owns 30,477 shares of the company’s stock valued at $1,243,000 after acquiring an additional 22,787 shares during the period. Finally, Chartwell Investment Partners LLC grew its position in Tivity Health by 194.6% in the third quarter. Chartwell Investment Partners LLC now owns 111,754 shares of the company’s stock valued at $4,559,000 after acquiring an additional 73,819 shares during the period.

How to Become a New Pot Stock Millionaire

In related news, CEO Donato Tramuto sold 20,000 shares of the stock in a transaction dated Monday, April 2nd. The stock was sold at an average price of $39.30, for a total transaction of $786,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 8.42% of the stock is currently owned by company insiders.

Shares of Tivity Health stock traded down $0.25 during trading hours on Friday, hitting $39.50. The company’s stock had a trading volume of 831,463 shares, compared to its average volume of 589,289. Tivity Health has a 12 month low of $27.95 and a 12 month high of $48.50. The company has a market capitalization of $1,571.51, a P/E ratio of 23.51, a price-to-earnings-growth ratio of 1.66 and a beta of 0.31.

Tivity Health (NASDAQ:TVTY) last announced its quarterly earnings results on Thursday, February 22nd. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.32 by $0.09. Tivity Health had a return on equity of 29.17% and a net margin of 11.44%. The company had revenue of $139.40 million during the quarter, compared to the consensus estimate of $138.22 million. During the same period in the prior year, the company earned $0.35 earnings per share. The company’s revenue for the quarter was up 11.6% compared to the same quarter last year. equities research analysts expect that Tivity Health will post 2.16 EPS for the current fiscal year.

A number of equities analysts have commented on TVTY shares. BidaskClub raised Tivity Health from a “hold” rating to a “buy” rating in a research note on Tuesday, March 6th. Zacks Investment Research raised Tivity Health from a “hold” rating to a “buy” rating and set a $44.00 price objective on the stock in a research note on Thursday, January 25th. Chardan Capital reaffirmed a “neutral” rating and set a $41.00 price target (down previously from $44.00) on shares of Tivity Health in a research note on Friday, February 23rd. Barrington Research upped their price target on Tivity Health from $40.00 to $47.00 and gave the company an “outperform” rating in a research note on Friday, February 23rd. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $53.00 price target on shares of Tivity Health in a research note on Friday, February 23rd. Two equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. Tivity Health presently has an average rating of “Buy” and a consensus target price of $46.88.

TRADEMARK VIOLATION NOTICE: This article was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another publication, it was illegally stolen and republished in violation of US and international trademark and copyright legislation. The original version of this article can be viewed at https://www.dispatchtribunal.com/2018/04/08/tivity-health-inc-tvty-shares-bought-by-rhumbline-advisers.html.

Tivity Health Company Profile

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers.

Institutional Ownership by Quarter for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply